$15.25
+0 (+0%)
At Close: Feb 17, 2023
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company's Ophthalmic Pharmaceutical Business
01:01am, Tuesday, 22'nd Nov 2022
GENEVA--( BUSINESS WIRE )--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has completed its acquisition of Aerie Pharmaceutic
Aerie Pharmaceuticals (AERI) Reports Q3 Loss, Tops Revenue Estimates
07:36pm, Thursday, 03'rd Nov 2022
Aerie (AERI) delivered earnings and revenue surprises of 35.71% and 2.91%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results
04:01pm, Thursday, 03'rd Nov 2022
DURHAM, N.C.
Add These 4 Top-Ranked Liquid Stocks For Healthy Gains
10:33am, Friday, 21'st Oct 2022
Here are four top-ranked liquid stocks, Oxford Industries (OXM), Aerie Pharmaceuticals (AERI), Perion Network (PERI), and Pure Storage (PSTG), which investors can add to their portfolio for returns.
5 Small Hidden Gems Flying High Despite Market's Bloodbath
09:47am, Friday, 21'st Oct 2022
We have narrowed our search to five small cap stocks that have provided more than 35% returns year to date,These are: AERI, AMAL, RELL, PHX and SBOW.
5 Stocks to Bet on in an Innovation-Driven Drug Industry
12:02pm, Thursday, 20'th Oct 2022
Innovation is expected continue driving growth in the Medical-Drugs industry in 2023. JAZZ, CPRX, AERI, LRMR and FUSN may prove to be good additions to one's portfolio.
Are Medical Stocks Lagging Aerie Pharmaceuticals (AERI) This Year?
11:17am, Monday, 17'th Oct 2022
Here is how Aerie Pharmaceuticals (AERI) and Mersana Therapeutics, Inc. (MRSN) have performed compared to their sector so far this year.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C.
Is Aerie Pharmaceuticals (AERI) Stock Outpacing Its Medical Peers This Year?
11:17am, Thursday, 29'th Sep 2022
Here is how Aerie Pharmaceuticals (AERI) and Hanger (HNGR) have performed compared to their sector so far this year.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AERI, ECOM, PFS, LBAI
01:14am, Wednesday, 28'th Sep 2022
NEW YORK , Sept. 28, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breache
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company focused on the discovery, development, and commercialization of first-in-class ophthalmic therapies,
Is Aerie Pharmaceuticals (AERI) Outperforming Other Medical Stocks This Year?
11:17am, Monday, 12'th Sep 2022
Here is how Aerie Pharmaceuticals (AERI) and Alignment Healthcare (ALHC) have performed compared to their sector so far this year.
Has Aerie Pharmaceuticals (AERI) Outpaced Other Medical Stocks This Year?
11:18am, Friday, 26'th Aug 2022
Here is how Aerie Pharmaceuticals (AERI) and Catalyst Pharmaceutical (CPRX) have performed compared to their sector so far this year.
Why Aerie Pharmaceuticals Was Soaring So High This Week
09:03am, Friday, 26'th Aug 2022
You'd vault skyward, too, if a big-pocketed company were willing to spend a lot of coin on acquiring you.
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates ONEM, CCXI, AERI, SFT
11:26am, Thursday, 25'th Aug 2022
NEW YORK , Aug. 25, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches
Sign In
Buy AERI